Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies

E-ISSN： 1873-4286|18|32|5141-5155

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.32, 2012-11, pp. : 5141-5155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4960-4965

Bentham Science Publishers

Access to resources Recommend Favorite

A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5131-5140

Bentham Science Publishers

Access to resources Recommend Favorite

Atypical antipsychotic-like effects of the dopamine D 3 receptor agonist, (+)-PD 128,907

By Witkin J. Gasior M. Acri J. Beekman M. Thurkauf A. Yuan J. DeBoer P. Wikstrom H. Dijkstra D.

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review

Current Neuropharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 422-434

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 953-960

Bentham Science Publishers

Access to resources Recommend Favorite